A year of growth and expansion characterise the Cancer Research Horizons Annual Review 2022/23, published today

Today, Cancer Research Horizons, the innovation arm of Cancer Research UK, published its Annual Review 2022/23. The review highlights the events and achievements that have defined the 2022/23 financial year and how strategic changes have enhanced the way Cancer Research Horizons translates discoveries into patient benefit.